Autoimmune Disease
- PMID: 32091795
- Bookshelf ID: NBK553982
- DOI: 10.1007/978-3-030-02278-5_91
Autoimmune Disease
Excerpt
Autoimmune diseases (ADs) are a heterogeneous group of diseases affecting 8–10% of the Western population, which constitute a heavy burden to society and are often debilitating and disabling for affected individuals.
Copyright 2019, EBMT and the Author(s).
Sections
- 91.1. Introduction
- 91.2. HSCT for Multiple Sclerosis (MS)
- 91.3. HSCT for Systemic Sclerosis (SSc)
- 91.4. HSCT for Systemic Lupus Erythematosus (SLE)
- 91.5. HSCT for Crohn’s Disease (CD)
- 91.6. Allogeneic HSCT for Autoimmune Diseases
- 91.7. Other Indications
- 91.8. Mechanisms of Action
- 91.9. Conclusions and Future Directions
- Acknowledgement
- References
References
-
- Alchi B, Jayne D, Labopin M, et al. Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry. Lupus. 2013;22:245–53. - PubMed
-
- Alexander T, Hiepe F. Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: time ready for a paradigm shift? Clin Exp Rheumatol. 2017;35:359–61. - PubMed
-
- Alexander T, Arnold R, Hiepe F, RAIDbruch A. Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases. Clin Exp Rheumatol. 2016;34:53–7. - PubMed
-
- Atkins HL, Bowman M, Allan D, et al. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet. 2016;388:576–85. - PubMed